Cancer stem cell overexpression of nicotinamide N-methyltransferase enhances cellular radiation resistance

Filippo P. D’Andrea, Akmal Safwat, Moustapha Kassem, Laurent Gautier, Jens Overgaard, Michael R. Horsman

    Research output: Contribution to journalJournal articleResearchpeer-review


    BackgroundCancer stem cells are thought to be a radioresistant population and may be the seeds for recurrence after radiotherapy. Using tumorigenic clones of retroviral immortalized human mesenchymal stem cell with small differences in their phenotype, we investigated possible genetic expression that could explain cancer stem cell radiation resistance. MethodsTumorigenic mesenchymal cancer stem cell clones BB3 and CE8 were irradiated at varying doses and assayed for clonogenic surviving fraction. Altered gene expression before and after 2Gy was assessed by Affymetric exon chip analysis and further validated with q-RT-PCR using TaqMan probes. ResultsThe CE8 clone was more radiation resistant than the BB3 clone. From a pool of 15 validated genes with altered expression in the CE8 clone, we found the enzyme nicotinamide N-methyltransferase (NNMT) more than 5-fold upregulated. In-depth pathway analysis found the genes involved in cancer, proliferation, DNA repair and cell death. ConclusionsThe higher radiation resistance in clone CE8 is likely due to NNMT overexpression. The higher levels of NNMT could affect the cellular damage resistance through depletion of the accessible amounts of nicotinamide, which is a known inhibitor of cellular DNA repair mechanisms.
    Original languageEnglish
    JournalRadiotherapy & Oncology
    Issue number3
    Pages (from-to)373-378
    Publication statusPublished - 2011


    • Nicotinamide
    • Radiation resistance
    • Cancer stem cells
    • NNMT


    Dive into the research topics of 'Cancer stem cell overexpression of nicotinamide N-methyltransferase enhances cellular radiation resistance'. Together they form a unique fingerprint.

    Cite this